I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Clevudine therapy for 24 weeks further reduced serum hepati..:
Lee, Kwan Sik
;
Byun, Kwan Soo
;
Chung, Young-Hwa
...
Intervirology. 2007;50(4):296-302. Epub 2007 Jul 9.. , 2007
Link:
https://hdl.handle.net/10371/29064
RT Journal T1
Clevudine therapy for 24 weeks further reduced serum hepatitis B virus DNA levels and increased ALT normalization rates without emergence of viral breakthrough than 12 weeks of clevudine therapy
UL https://suche.suub.uni-bremen.de/peid=base-ftseoulnuniv:oai:s-space.snu.ac.kr:10371_29064&Exemplar=1&LAN=DE A1 Lee, Kwan Sik A1 Byun, Kwan Soo A1 Chung, Young-Hwa A1 Paik, Seung Woon A1 Han, Joon-Yeol A1 Yoo, Kwon A1 Yoo, Hee-Won A1 Yoo, Byung Chul A1 Lee, Hyo-Suk PB Karger YR 2007 K1 Alanine Transaminase/*blood K1 Arabinofuranosyluracil/administration & dosage/adverse effects/*analogs & K1 derivatives/therapeutic use K1 DNA K1 Viral/*blood K1 Hepatitis B e Antigens/blood K1 Hepatitis B virus/*drug effects/genetics/isolation & K1 purification/physiology K1 Hepatitis B K1 Chronic/drug therapy/virology K1 Humans K1 Male K1 Treatment Outcome K1 Antiviral Agents/administration & dosage/adverse effects/therapeutic use JF Intervirology. 2007;50(4):296-302. Epub 2007 Jul 9. LK http://dx.doi.org/https://hdl.handle.net/10371/29064 DO https://hdl.handle.net/10371/29064 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)